Myomo (MYO) Share-based Compensation Growth (3y) (2019 - 2025)
Myomo (MYO) Share-based Compensation Growth (3y) (2019 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 4.10% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 23.38% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 8.20% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 14.70% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 5.29% |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 0.56% |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | - |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 13.40% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Myomo | 39.24 Mn | 20.27 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 24.09% |
| Jun 30, 2025 | 4.58% |
| Mar 31, 2025 | 26.59% |
| Sep 30, 2024 | 2.42% |
| Jun 30, 2024 | -31.09% |
| Mar 31, 2024 | 24.50% |
| Sep 30, 2023 | 22.06% |
| Jun 30, 2023 | 38.12% |
| Mar 31, 2023 | 11.55% |
| Dec 31, 2022 | 17.69% |
| Sep 30, 2022 | 27.65% |
| Jun 30, 2022 | 20.56% |
| Mar 31, 2022 | -12.42% |
| Sep 30, 2021 | 25.99% |
| Jun 30, 2021 | 32.63% |
| Mar 31, 2021 | -20.98% |
| Dec 31, 2020 | -128.40% |
| Sep 30, 2020 | -4.44% |
| Jun 30, 2020 | 120.89% |
| Mar 31, 2020 | 82.89% |